141 related articles for article (PubMed ID: 3345759)
1. Interaction of a spin-labelled cholesterol derivative with the cytochrome P-450scc active site.
Lange R; Maurin L; Larroque C; Bienvenüe A
Eur J Biochem; 1988 Feb; 172(1):189-95. PubMed ID: 3345759
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of electron transfer from adrenodoxin to cytochrome P-450scc by chemical modification with pyridoxal 5'-phosphate: identification of adrenodoxin-binding site of cytochrome P-450scc.
Tsubaki M; Iwamoto Y; Hiwatashi A; Ichikawa Y
Biochemistry; 1989 Aug; 28(17):6899-907. PubMed ID: 2819041
[TBL] [Abstract][Full Text] [Related]
3. Active site-directed inhibitors of cytochrome P-450scc. Structural and mechanistic implications of a side chain-substituted series of amino-steroids.
Sheets JJ; Vickery LE
J Biol Chem; 1983 Oct; 258(19):11446-52. PubMed ID: 6688621
[TBL] [Abstract][Full Text] [Related]
4. Side-chain specificities of human and bovine cytochromes P-450scc.
Tuckey RC; Cameron KJ
Eur J Biochem; 1993 Oct; 217(1):209-15. PubMed ID: 8223556
[TBL] [Abstract][Full Text] [Related]
5. 22-Ketocholesterol. A potent competitive inhibitor of cytochrome P-450scc-dependent side-chain cleavage of cholesterol.
Lambeth JD
Mol Pharmacol; 1983 May; 23(3):743-7. PubMed ID: 6688121
[TBL] [Abstract][Full Text] [Related]
6. The catalytic cycle of cytochrome P-450scc and intermediates in the conversion of cholesterol to pregnenolone.
Hume R; Kelly RW; Taylor PL; Boyd GS
Eur J Biochem; 1984 May; 140(3):583-91. PubMed ID: 6723652
[TBL] [Abstract][Full Text] [Related]
7. Electron paramagnetic resonance study of ferrous cytochrome P-450scc-nitric oxide complexes: effects of 20(R),22(R)-dihydroxycholesterol and reduced adrenodoxin.
Tsubaki M; Hiwatashi A; Ichikawa Y; Fujimoto Y; Ikekawa N; Hori H
Biochemistry; 1988 Jun; 27(13):4856-62. PubMed ID: 2844242
[TBL] [Abstract][Full Text] [Related]
8. Active site of bovine adrenocortical cytochrome P-450(11) beta studied by resonance Raman and electron paramagnetic resonance spectroscopies: distinction from cytochrome P-450scc.
Tsubaki M; Ichikawa Y; Fujimoto Y; Yu NT; Hori H
Biochemistry; 1990 Sep; 29(37):8805-12. PubMed ID: 2176837
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P-450 of adrenal mitochondria. Spin states as detected by difference spectroscopy.
Jefcoate CR
J Biol Chem; 1975 Jun; 250(12):4663-70. PubMed ID: 167000
[TBL] [Abstract][Full Text] [Related]
10. pH modulation of ligand binding to adrenal mitochondrial cytochrome P-450scc.
Jefcoate CR
J Biol Chem; 1982 May; 257(9):4731-7. PubMed ID: 7068661
[TBL] [Abstract][Full Text] [Related]
11. Effects of phospholipid and detergent on the substrate specificity of adrenal cytochrome P-450scc. Substrate binding and kinetics of cholesterol side chain oxidation.
Greenfield NJ; Gerolimatos B; Szwergold BS; Wolfson AJ; Prasad VV; Lieberman S
J Biol Chem; 1981 May; 256(9):4407-17. PubMed ID: 6260797
[TBL] [Abstract][Full Text] [Related]
12. Cross-linking studies of adrenocortical cytochrome P-450scc. Evidence for a covalent complex with adrenodoxin and localization of the adrenodoxin-binding domain.
Chashchin VL; Turko IV; Akhrem AA; Usanov SA
Biochim Biophys Acta; 1985 Apr; 828(3):313-24. PubMed ID: 3838683
[TBL] [Abstract][Full Text] [Related]
13. Conversion of cholesterol to pregnenolone mobilizes cytochrome P-450 in the inner membrane of adrenocortical mitochondria: protein rotation study.
Ohta Y; Mitani F; Ishimura Y; Yanagibashi K; Kawamura M; Kawato S
J Biochem; 1990 Jan; 107(1):97-104. PubMed ID: 2332425
[TBL] [Abstract][Full Text] [Related]
14. Studies of the active site of cytochrome P-450scc with a high-affinity spin-labeled inhibitor.
Seeley D; Schleyer H; Kashiwagi K; Cooper D; Salhanick HA
Biochemistry; 1987 Mar; 26(5):1270-5. PubMed ID: 3032247
[TBL] [Abstract][Full Text] [Related]
15. Cross-linking studies of the cholesterol hydroxylation system from bovine adrenocortical mitochondria.
Turko IV; Adamovich TB; Kirillova NM; Usanov SA; Chashchin VL
Biochim Biophys Acta; 1989 Jun; 996(1-2):37-42. PubMed ID: 2736257
[TBL] [Abstract][Full Text] [Related]
16. Electron transfer to cytochrome P-450scc limits cholesterol-side-chain-cleavage activity in the human placenta.
Tuckey RC; Woods ST; Tajbakhsh M
Eur J Biochem; 1997 Mar; 244(3):835-9. PubMed ID: 9108254
[TBL] [Abstract][Full Text] [Related]
17. Catalytic properties of cytochrome P-450scc purified from the human placenta: comparison to bovine cytochrome P-450scc.
Tuckey RC; Cameron KJ
Biochim Biophys Acta; 1993 May; 1163(2):185-94. PubMed ID: 8490050
[TBL] [Abstract][Full Text] [Related]
18. Purification and comparative characterization of cytochrome P-450scc from porcine adrenocortical mitochondria.
Iwahashi K; Tsubaki M; Miyatake A; Ichikawa Y
Int J Biochem; 1991; 23(9):901-9. PubMed ID: 1773895
[TBL] [Abstract][Full Text] [Related]
19. Electron paramagnetic resonance study of ferrous cytochrome P-450scc-nitric oxide complexes: effects of cholesterol and its analogues.
Tsubaki M; Hiwatashi A; Ichikawa Y; Hori H
Biochemistry; 1987 Jul; 26(14):4527-34. PubMed ID: 2822097
[TBL] [Abstract][Full Text] [Related]
20. Proximity of the substrate binding site and the heme-iron catalytic site in cytochrome P-450scc.
Sheets JJ; Vickery LE
Proc Natl Acad Sci U S A; 1982 Oct; 79(19):5773-7. PubMed ID: 6964388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
